The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.

Viruses · 2024 · PMC10976088 · PMID 38543783

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Consistent with the previous determinations, the G4 (N + ODN-39M, intranasally administered) showed a clear trend to generate the highest response ( Figure 2 c). 3.2.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.